Monoclonal antibody bamlanivimab(LY-CoV555; Lilly) has been granted as FDA Emergency Use Authorization for treatment of recently diagnosed mild to moderate COVID-19 in patients who are older than 12 years old, weigh at least 40 kg, and are at high risk for progressing to severe disease and /or hospitalization. It is about 1-hour infusion without hospitalization
Patients with at least 1 of the following:
Patients over 55 years old with at least one of the following:
After exposure to COVID-19, most of the people start to have symptoms within 10-14 days
*Aspirin, Tylenol, Mortin, Advil, Aleve will lower your temperature, take your temperature before your next dose.
Pfizer and Moderna vaccines were approved by the FDA for emergency use to prevent coronavirus disease-2019 (COVID-19)
The best way per CDC to prevent illness is to avoid being exposed to this virus.
10 Things You Can Do to Manage COVID-19 at Home